EQT reportedly in advanced talks to buy Qiagen for over $50 a share; KKR also said to bid

EQT is said to be in advanced talks to buy diagnostics firm Qiagen, with a reported bid valued at more than $50 per share, totaling over €9 billion. KKR is also reported to have bid. Qiagen's supervisory board is expected to meet to discuss the matter.

Detected & updated continuously · Source: Nebula